MoneyWorks4Me

Akums Drugs reports 58% jump in Q1 consolidated net profit

10 Aug 2026 Evaluate

Akums Drugs and Pharmaceuticals has reported results for first quarter ended June 30, 2026 (Q1FY27).

The company has reported marginal fall by 0.07% in its net profit at Rs 44.84 crore for the quarter ended June 30, 2026 as compared to Rs 44.87 crore for the same quarter in the previous year. However, total income of the company has increased by 15.90% at Rs 418.38 crore for Q1FY27 as compared to Rs 361.00 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported 57.55% jump in its net profit at Rs 100.01 crore for Q1FY27 as compared to Rs 63.48 crore for the same quarter in the previous year. The total income of the company has increased by 13.92% at Rs 1,197.01 crore for Q1FY27 as compared to Rs 1,050.76 crore for the corresponding quarter previous year.

Akums Drugs & Pharma Share Price

754.00 -7.00 (-0.92%)
12-Aug-2026 09:55 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1936.20
Dr. Reddys Labs. 1192.05
Cipla 1459.35
Lupin 2267.60
Zydus Lifesciences 1159.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: